Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Non-Current Deferred Tax Liability (2021 - 2025)

Sensus Healthcare has reported Non-Current Deferred Tax Liability over the past 5 years, most recently at $12000.0 for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 42.86% year-over-year to $12000.0; the TTM value through Dec 2025 reached $12000.0, down 42.86%, while the annual FY2025 figure was $12000.0, 42.86% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $12000.0 at Sensus Healthcare, down from $21000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $1.7 million in Q4 2022 and troughed at $12000.0 in Q4 2025.
  • A 5-year average of $374600.0 and a median of $21000.0 in 2024 define the central range for Non-Current Deferred Tax Liability.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: surged 1457.27% in 2022 and later crashed 99.01% in 2023.
  • Year by year, Non-Current Deferred Tax Liability stood at $110000.0 in 2021, then surged by 1457.27% to $1.7 million in 2022, then crashed by 99.01% to $17000.0 in 2023, then grew by 23.53% to $21000.0 in 2024, then plummeted by 42.86% to $12000.0 in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for SRTS at $12000.0 in Q4 2025, $21000.0 in Q4 2024, and $17000.0 in Q4 2023.